We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
BIO-RAD LABORATORIES

Download Mobile App




New Program Encourages Wide Distribution of Genomic Data

By LabMedica International staff writers
Posted on 28 Oct 2014
Print article
A new data sharing program allows genomics researchers and practitioners to analyze, visualize, and share raw sequence data for individual patients or across populations straight from a local browser.

The sequencing revolution is providing the raw data required to identify the genetic variants underlying rare diseases and complex traits alike. The NextCODE (Cambridge, MA, USA) Exchange was designed to meet the next challenge: it links the researcher to a proven sequence analysis platform and enables secure and seamless collaboration and validation of findings with colleagues and institutions around the world.

The Exchange is powered by NextCODE’s unique GOR informatics system. Optimized on whole-genome data from 350,000 people, it standardizes, manages, and queries massive sequence data with unrivalled computational efficiency. The user can visualize aligned raw sequences and collaborate and share data—in full compliance with individually established rules and consents, without transferring big files, straight from a local browser.

"The genomics community is now generating the sequence data to solve more rare disease cases and find high-impact variants in complex traits. The ability to visually confirm findings in raw sequence at a click, and to validate findings by securely sharing data with other researchers working on the same diseases elsewhere, will help to crack more difficult diagnostic cases and speed discovery. We have a fantastic group of launch partners, global leaders in rare disease and autism research, who will be able to use and demonstrate the Exchange's scalability and reach," said Dr. Jeffrey Gulcher, president and CSO of NextCODE.

Related Links:

NEXTCOODE
NEXTCODE Video


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
TORCH Panel Rapid Test
Rapid TORCH Panel Test

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A blood test could predict lung cancer risk more accurately and reduce the number of required scans (Photo courtesy of 123RF)

Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans

Lung cancer is extremely hard to detect early due to the limitations of current screening technologies, which are costly, sometimes inaccurate, and less commonly endorsed by healthcare professionals compared... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Pathology

view channel
Image: Comparison of traditional histopathology imaging vs. PARS raw data (Photo courtesy of University of Waterloo)

AI-Powered Digital Imaging System to Revolutionize Cancer Diagnosis

The process of biopsy is important for confirming the presence of cancer. In the conventional histopathology technique, tissue is excised, sliced, stained, mounted on slides, and examined under a microscope... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.